The study included 200 men (18–27 years old) divided into 4 equal groups: participants in group 3 received one of the antiviral drugs in a standard dosage, group 4 was a control group with pathogenetic therapy alone. The severity and duration of clinical symptoms of ARVI, the duration of hospitalization, the frequency of complications, as well as the presence of viral pathogens (based on the results of polymerase chain reaction on days 1 and 6) were assessed.
Quantitative variables are represented as median (Me) and interquartile interval (Q1; Q3) or mean (M) and standard deviation (SD). Verification of compliance with the normal distribution was carried out using the Shapiro–Wilk test. Statistical analyses included non-parametric methods, tests.
To compare the indicators between the four independent groups, the nonparametric Kruskel-Wallis test was used. In case of statistically significant differences (p<0.05), pairwise comparisons were made using the Mann–Whitney test with Bonferroni’s correction for multiplicity comparisons.
Efficacy of antiviral therapy in late treatment Acute respiratory viral infection: data from a comparative observational study
